Second, two-wheeler sales will continue to be strong around 12%, 13%, 14% depending on the company. Bajaj and TVS Motors I think still will continue to be strong. On the other hand passenger vehicles, some amount of inventories are building up clearly and so whether the dealer profitability will go down, does not really affect OEMs. So, I think Maruti will tread water. Commercial vehicle sales on the other hand have not picked up.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,
August 19, 2026